Join Us at CPHI China 2025

Date: June 24–26, 2025
Location: Booth E3D26, Shanghai New International Expo Center

Be part of the momentum at CPHI China 2025, Asia’s premier pharmaceutical event. This global gathering brings together over 100,000 professionals from 140+ countries, offering a powerful platform to connect, discover, and grow.

This year marks an exciting new chapter — IFF Pharma Solutions is now part of Roquette. At CPHI China 2025, we’re proud to present our legacy IFF Pharma Solutions’ portfolio of innovative excipients, designed to address complex formulation challenges that support the development of next-generation drug delivery systems.

What to Expect

At booth E3D26, explore how our advanced excipients are enabling the future of drug delivery. Whether you're developing controlled release systems or tackling complex formulation challenges, our team is here to collaborate and inspire. We’re focused on helping you formulate the future with science backed scalable solutions that unlock complex formulations and open endless opportunities for innovation.

Innovation in Focus

  • Advanced Controlled Release – Next-generation delivery systems for enhanced therapeutic efficacy
  • Complex Formulations – Solutions for solubility, stability, and bioavailability
  • Safer Excipients – Low nitrite innovations for compliant, patient-centric development

Explore the Dynamic Display

Discover a selection of innovative formulations at our sample display area, each showcasing the performance and versatility of our excipients. Explore Mirabegron extended release tablets formulated with Polyethylene Oxide (PEO) in a matrix system for controlled drug release, and Sitagliptin phosphate tablets using Avicel® PH LN to enhance compressibility and tablet integrity. See how Multiparticulate tablets leverage Avicel® as a cushioning agent to protect sensitive granules during compression. For patient-friendly delivery, we’re featuring veggie soft capsules made with SeaGel®, offering a plant-based alternative to gelatin, and oral films incorporating PEO and Hydroxypropyl Methylcellulose for fast-dissolving, convenient administration. These prototypes reflect our commitment to solving complex formulation challenges with precision and innovation.

Each formulation tells a story of innovation, precision, and patient care.

Let’s Connect

Whether you're a formulator, innovator, or decision-maker, we invite you to stop by and explore how we can help bring your next breakthrough to life.